Cargando…
Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma
Melanoma is one of the most aggressive cancers in the world and is responsible for the majority of skin cancer deaths. Recent advances in the field of immunotherapy using active, adoptive, and antigen-specific therapeutic approaches, have generated the expectation that these technologies have the po...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chonnam National University Medical School
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636755/ https://www.ncbi.nlm.nih.gov/pubmed/29026704 http://dx.doi.org/10.4068/cmj.2017.53.3.173 |